Lazard Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52K | Sell |
|
|||||
|
2025
Q1 | $200K | Sell |
|
|||||
|
2024
Q4 | $1.71M | Buy |
|
|||||
|
2024
Q3 | $1.27M | Buy |
|
|||||
|
2024
Q2 | $698K | Sell |
|
|||||
|
2024
Q1 | $884K | Sell |
|
|||||
|
2023
Q4 | $3.12M | Sell |
|
|||||
|
2023
Q3 | $3.45M | Buy |
|
|||||
|
2023
Q2 | $1.53M | Sell |
|
|||||
|
2023
Q1 | $3.59M | Buy |
|
|||||
|
2022
Q4 | $3.29M | Sell |
|
|||||
|
2022
Q3 | $3.25M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2.24M | Buy |
|
|||||
|
2021
Q3 | $3K | Hold |
|
|||||
|
2021
Q2 | $3K | Sell |
|
|||||
|
2021
Q1 | $3.73M | Buy |
|
|||||
|
2020
Q4 | $50K | Hold |
|
|||||
|
2020
Q3 | $36K | Buy |
|
|||||
|
2020
Q2 | $21K | Sell |
|
|||||
|
2020
Q1 | $70K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $362K | Buy |
|
|||||
|
2018
Q3 | $62K | Sell |
|
|||||
|
2018
Q2 | $390K | Sell |
|
|||||
|
2018
Q1 | $548K | Buy |
|
|||||
|
2017
Q4 | $274K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $8.06M | Sell |
|
|||||
|
2013
Q3 | $9.86M | Buy |
|
|||||
|
2013
Q2 | $10.1M | Buy |
|